DOI: 10.1097/01.wad.0000190801.26587.8a

,  

Issn Print: 0893-0341

Publication Date: 2005/10/01


Print

Introduction

Peggye Dilworth-Anderson; Ramón Valle; Sam Fazio; Teresa Radebaugh

    loading  Checking for direct PDF access through Ovid

Excerpt

The symposium, “Assessment, Diagnosis and Interventions in Culturally Diverse Older Populations with Alzheimer's Disease: Research Directions,” was convened on October 28-29, 2004, in Chapel Hill, North Carolina by the Alzheimers Association in partnership with the University of North Carolina's Center for Aging and Diversity and Institute on Aging. The goals of the symposium were threefold: (1) to examine the actual heterogeneity of older people with Alzheimer disease (AD); (2) to explore the implications of population heterogeneity for the cross-cultural assessment, diagnosis, treatment, and intervention in AD; and (3) to highlight strategies for expediting the inclusion of diverse populations into AD research and treatment interventions.
Each of the papers that follow in this issue represents the exchange of ideas that took place at the symposium. The series of questions below were developed as a guide to future research on Alzheimer disease in diverse populations:
The demographic clock is ticking and the answers to these questions must be found to ultimately eradicate Alzheimer disease within the whole of the US population, as well as the rest of the world. At present ethnically diverse persons represent approximately one-fifth of all dementia-impacted persons. By 2010 they will represent one quarter, and by 2030+ they will constitute a full one third of the expected 9 million Alzheimer and associated disorders sufferers in the United States. Progress in both research and clinical treatment need to be measured with reference to how culturally inclusive, and how comprehensively extended, they are to all of the nation's diverse peoples. Peggye Dilworth-Anderson, PhD, University of North Carolina at Chapel Hill; Ramon, Valle, PhD, San Diego State University; Sam Fazio, PhD, Alzheimer's Association, and Teresa Radebaugh, Sc. D., Khachaturian, Radebaugh & Associates, Inc., El Darado, Kansan.

Related Topics

    loading  Loading Related Articles